Insight into the relationship between forced vital capacity and transfer of the lungs for carbon monoxide in patients with idiopathic pulmonary fibrosis

被引:0
|
作者
Soumagne, Thibaud
Quetantb, Sebastien [2 ]
Guillien, Alicia [3 ]
Falque, Loic [2 ]
Hess, David [4 ]
Aguilaniu, Bernard [4 ,5 ]
Degano, Bruno [1 ,6 ,7 ]
机构
[1] Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Serv Pneumol & Reanimat Resp, Clamart, France
[2] Ctr Hosp Univ Grenoble Alpes, Serv Hosp Univ Pneumol Physiol, Pole Thorax & Vaisseaux, Grenoble, France
[3] Univ Grenoble Alpes, Inst Avancee Biosci IAB, Epidemiol Environm Appl Reprod & Sante Resp, INSERM,CNRS,U1209, Grenoble, France
[4] Assoc Complementar Connaissances & Prat Pneumol a, Programme Colibri, 19 Ave Marcelin Berthelot, F-38100 Grenoble, France
[5] Univ Grenoble Alpes, Grenoble, France
[6] Univ Grenoble Alpes, Lab HP2, INSERM U1300, Grenoble, France
[7] CHU Grenoble Alpes, Serv Hosp Univ Pneumol Physiol, F-38043 Grenoble, France
来源
关键词
Idiopathic pulmonary fibrosis; Pulmonary function tests; Forced vital capacity; Transfer of the lungs for carbon monoxide; Introduction; CLINICAL-PRACTICE; REFERENCE VALUES; DISEASE; PREDICTION; DIAGNOSIS; SURVIVAL; DLCO; KCO; FVC;
D O I
10.1016/j.resmer.2023.101042
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Forced vital capacity (FVC) is routinely used to quantify the severity and identify the progression of idiopathic pulmonary fibrosis (IPF). Although less commonly used, lung transfer of carbon monoxide (TLCO) correlates better with the severity of IPF than does FVC.Methods: Aiming at studying how FVC behaves in relation to TLCO, we analysed cross-sectional data from 430 IPF patients, of which 221 had at least 2 assessments (performed 2.4 +/- 1.9 years apart) available for longitudinal analyses. Thresholds for identifying "abnormal" FVC and TLCO values were the statistically-defined lower limits of normal (LLN). For patients with longitudinal data, mean annual absolute declines of FVC and TLCO were calculated. Results: The correlation between FVC and TLCO (%predicted) was weak (R2=0.21). FVC was "abnormal" (i.e., 38% of patients while 84% of patients had an "abnormal" TLCO. A large majority of the 268 patients with a "normal" FVC had nevertheless an "abnormal" TLCO (n = 209; 78%). On longitudinal analysis, 67/221 patients had an annual absolute decline in FVC >= 5%, 34/221 had an annual absolute decline in TLCO >= 10%, and 22 had both.Conclusion: In IPF, a "normal" FVC should be viewed with caution as it is most often associated with an "abnormal" TLCO, a parameter that is strongly correlated with the morphological extent of the disease. Only 1/3 of the patients with a FVC-based progression criterion also had a TLCO progression criterion. In contrast, 2/3 of patients with a TLCO progression criterion also had a FVC progression criterion.(c) 2023 Published by Elsevier Masson SAS.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] THE RELATIONSHIP BETWEEN OSCILLATORY IMPEDANCE AND FUNCTIONAL EXERCISE CAPACITY IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
    Shirol, R.
    Seccombe, L.
    Veitch, E.
    Nilsen, K.
    Farah, C.
    Chapman, D.
    RESPIROLOGY, 2020, 25 : 75 - 75
  • [42] THE RELATIONSHIP BETWEEN OSCILLATORY IMPEDANCE AND FUNCTIONAL EXERCISE CAPACITY IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
    Shirol, R.
    RESPIROLOGY, 2021, 26 : 94 - 94
  • [43] Relationship between Forced Vital Capacity and Slow Vital Capacity in individuals with Amyotropic Lateral Sclerosis Patients
    Reynolds, Jerold
    NEUROLOGY, 2019, 92 (15)
  • [44] Prognostic significance of forced vital capacity decline prior to and following antifibrotic therapy in idiopathic pulmonary fibrosis
    Aono, Yuya
    Nakamura, Yutaro
    Kono, Masato
    Nakamura, Hidenori
    Yokomura, Koshi
    Imokawa, Shiro
    Toyoshima, Mikio
    Yasui, Hideki
    Hozumi, Hironao
    Karayama, Masato
    Suzuki, Yuzo
    Furuhashi, Kazuki
    Enomoto, Noriyuki
    Fujisawa, Tomoyuki
    Inui, Naoki
    Suda, Takafumi
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2020, 14
  • [45] Decline in forced vital capacity (FVC) in subjects with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) compared with healthy references
    Valenzuela, Claudia
    Bonella, Francesco
    Moor, Catharina C.
    Weimann, Gerrit
    Miede, Corinna
    Stowasser, Susanne
    Maher, Toby M.
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [46] Pretreatment rate of decay in forced vital capacity predicts long-term response to pirfenidone in patients with idiopathic pulmonary fibrosis
    Biondini, Davide
    Balestro, Elisabetta
    Lacedonia, Donato
    Cerri, Stefania
    Milaneschi, Rosanna
    Luppi, Fabrizio
    Cocconcelli, Elisabetta
    Bazzan, Erica
    Clini, Enrico
    Barbaro, Maria Pia Foschino
    Gregori, Dario
    Cosio, Manuel G.
    Saetta, Marina
    Spagnolo, Paolo
    SCIENTIFIC REPORTS, 2018, 8
  • [47] A NEW METHOD TO EVALUATE THE CLINICAL EFFICACY OF PIRFENIDONE FOR PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS BY USING PERSONAL FORCED VITAL CAPACITY CHANGE
    Yamauchi, Hiroyoshi
    Bando, Masashi
    Ogura, Takashi
    Suda, Takafumi
    Taniguchi, Hiroyuki
    Mukae, Hiroshi
    Kishi, Kazuma
    Sugiyama, Yukihiko
    RESPIROLOGY, 2014, 19 : 151 - 151
  • [48] Validation of A 25-Gene Blood Transcriptomic Signature Predictive of Forced Vital Capacity Decline in Patients With Idiopathic Pulmonary Fibrosis
    Bonham, C.
    Neely, M. L.
    Huang, Y.
    Ma, S.
    Kim, J. S.
    Oldham, J. M.
    Becker, K.
    Soellner, J.
    Todd, J. L.
    Noth, I.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [49] Pretreatment rate of decay in forced vital capacity predicts long-term response to pirfenidone in patients with idiopathic pulmonary fibrosis
    Davide Biondini
    Elisabetta Balestro
    Donato Lacedonia
    Stefania Cerri
    Rosanna Milaneschi
    Fabrizio Luppi
    Elisabetta Cocconcelli
    Erica Bazzan
    Enrico Clini
    Maria Pia Foschino Barbaro
    Dario Gregori
    Manuel G Cosio
    Marina Saetta
    Paolo Spagnolo
    Scientific Reports, 8
  • [50] Functional capacity in idiopathic pulmonary fibrosis: Looking beyond the lungs
    Holland, Anne E.
    RESPIROLOGY, 2015, 20 (06) : 857 - 858